BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2827482)

  • 1. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
    Shoupe D; Mishell DR; Page MA; Madkour H; Spitz IM; Lobo RA
    Am J Obstet Gynecol; 1987 Dec; 157(6):1421-6. PubMed ID: 2827482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
    Permezel JM; Lenton EA; Roberts I; Cooke ID
    J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation.
    Batista MC; Cartledge TP; Zellmer AW; Nieman LK; Merriam GR; Loriaux DL
    J Clin Endocrinol Metab; 1992 Mar; 74(3):565-70. PubMed ID: 1740491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase.
    Shoupe D; Mishell DR; Lahteenmaki P; Heikinheimo O; Birgerson L; Madkour H; Spitz IM
    Am J Obstet Gynecol; 1987 Dec; 157(6):1415-20. PubMed ID: 2827481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?
    Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1270-6. PubMed ID: 3097053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration.
    Danforth DR; Dubois C; Ulmann A; Baulieu EE; Hodgen GD
    Contraception; 1989 Aug; 40(2):195-200. PubMed ID: 2503298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteal contraception.
    Yen S; Garzo G; Liu J
    Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle.
    Stuenkel CA; Garzo VG; Morris S; Liu JH; Yen SS
    Fertil Steril; 1990 Apr; 53(4):642-6. PubMed ID: 2156736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects.
    Healy DL; Baulieu EE; Hodgen GD
    Fertil Steril; 1983 Aug; 40(2):253-7. PubMed ID: 6307760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pre-ovulatory progesterone in the midcycle gonadotrophin surge, ovulation and subsequent luteal phase: studies with RU486 in rhesus monkeys.
    Remohi J; Balmaceda JP; Rojas FJ; Asch RH
    Hum Reprod; 1988 May; 3(4):431-5. PubMed ID: 3134390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.